But Labor Health Minister Chris Bowen said Australia had fallen behind other countries in securing a vaccine deal, calling on Mr Hunt to"assure us that we are not at a disadvantage because we are so far behind the rest of the world".
Three Australian vaccines are in the mix too, having completed phase one trials at the University of Queensland, the University of Melbourne and Flinders University in Adelaide.Flinders University’s Professor Nikolai Petrovsky and founder of biotechnology company Vaxine said his team is so far seeing positive results but there is still some time to go.
“So we're particularly interested to go early into those vulnerable populations because that's where the vaccine is going to ultimately need to work, and where it will have its biggest impact."Phase three, which Professor Petrovsky described as “like getting to the top of Everest,” will be the biggest challenge.
Professor Tony Cunningham, the co-director of the Westmead Institute's Centre for Virus Research and part of a team of scientists advising the government, said it is important we don’t put all our eggs in one basket."You can fall over at any time during this process and so if you try and judge this ahead of time, you can say 'yes that looks good, and maybe we'll put our money on that vaccine candidate', but it may not necessarily work in the long run,” he said.
"Short-circuiting this process runs the risk of not understanding the efficacy of the vaccine and not being sufficiently assured that the vaccine will be safe."
Russia already found it, anything else will be second rate.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: SBSNews - 🏆 3. / 89 Read more »